Literature DB >> 6185617

Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.

S C Meuer, K A Fitzgerald, R E Hussey, J C Hodgdon, S F Schlossman, E L Reinherz.   

Abstract

Monoclonal antibodies were produced against a human cytotoxic T cell clone, CT8III (specificity: HLA-A3), with the view of defining clonally restricted (clonotypic) surface molecules involved in its antigen recognition function. Two individual antibodies, termed anti-Ti1A and anti-Ti1B, reacted exclusively with the CT8III clone when tested on a panel of 80 additional clones from the same donor, resting or activated T cells, B cells, macrophages, thymocytes, or other hematopoietic cells. More importantly, the two antibodies inhibited cell-mediated killing and antigen-specific proliferation of the CT8III clone but did not affect the functions of any other clone tested. This inhibition was not secondary to generalized abrogation of the CT8III clone's function, because interleukin 2 responsiveness was enhanced. To examine the relationship of the structures defined by anti-clonotypic antibodies with known T cell surface molecules, antibody-induced modulation studies and competitive binding assays were performed. The results indicated that the clonotypic structures were associated with, but distinct from, the 20,000-mol wt T3 molecule expressed on all mature T lymphocytes. Moreover, in contrast to anti-T3, anti-Ti1A and anti-Ti1B each immunoprecipitated two molecules of 49,000 and 43,000-mol wt from 131I-labeled CT8III cells under reducing conditions. The development of monoclonal antibodies to such polymorphic T cell surface structures should provide important probes to further define the surface receptor for antigen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185617      PMCID: PMC2186929          DOI: 10.1084/jem.157.2.705

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  46 in total

1.  Antigen recognition: the specificity of T cells involved in the cellular immune response.

Authors:  S F Schlossman
Journal:  Transplant Rev       Date:  1972

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Antigen-specific suppressive factor produced by a transplantable I-J bearing T-cell hybridoma.

Authors:  M Taniguchi; T Saito; T Tada
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

4.  Production of an H--2-related suppressor factor by a hybrid T-cell line.

Authors:  M J Taussig; J R Corvalan; R M Binns; A Holliman
Journal:  Nature       Date:  1979-01-25       Impact factor: 49.962

Review 5.  Expression and function of idiotypes of lymphocytes.

Authors:  K Eichmann
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

6.  Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. V. Biochemical and serological characteristics of naturally occurring, soluble antigen-binding T-lymphocyte-derived molecules.

Authors:  H Binz; H Wigzell
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) III. Immunochemical properties of the GAT-specific suppressive factor.

Authors:  J Theze; J A Kapp; B Benacerraf
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

8.  Lymphocyte specificity to protein antigens. II. Fine specificity of T-cell activation with cytochrome c and derived peptides as antigenic probes.

Authors:  G Corradin; J M Chiller
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

9.  Isolated hapten-binding receptors of sensitized lymphocytes. III. Evidence for idiotypic restriction of T-cell receptors.

Authors:  U Krawinkel; M Cramer; I Melchers; T Imanishi-Kari; K Rajewsky
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

10.  Mechanisms of regulation of cell-mediated immunity. III. The characterization of azobenzenearsonate-specific suppressor T-cell-derived-suppressor factors.

Authors:  M I Greene; B A Bach; B Benacerraf
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

View more
  239 in total

1.  Preparation of anti-T idiotype monoclonal antibody reacting with human T leukaemic cell lines and with a small percentage of peripheral T lymphocytes.

Authors:  T Takahashi; K Imai; T Sugiyama; T Sasaki; A Yachi
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis.

Authors:  B Balbi; D R Moller; M Kirby; K J Holroyd; R G Crystal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award.

Authors:  Jillian H Hurst
Journal:  J Clin Invest       Date:  2015-09-08       Impact factor: 14.808

4.  Functional analysis of peripheral blood lymphocytes isolated from patients with chronic hepatitis type B.

Authors:  C García-Monzón; R Moreno-Otero; L García-Buey; M López-Botet; M O De Landázuri; F Sánchez-Madrid
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

5.  HIV-associated myocarditis. Pathology and immunopathology.

Authors:  W E Beschorner; K Baughman; R P Turnicky; G M Hutchins; S A Rowe; A L Kavanaugh-McHugh; D L Suresch; A Herskowitz
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

Review 6.  Following the cytokine signaling pathway to leukemogenesis: a chronology.

Authors:  Kendall A Smith; James D Griffin
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

7.  T cell receptors and immunoregulation.

Authors:  L S Rayfield
Journal:  J R Soc Med       Date:  1985-12       Impact factor: 5.344

8.  Heterogeneity of T cell receptor idiotypes in rheumatoid arthritis.

Authors:  F M Brennan; S Allard; M Londei; C Savill; A Boylston; S Carrel; R N Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone.

Authors:  U D Staerz; M S Pasternack; J R Klein; J D Benedetto; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.

Authors:  U D Staerz; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.